HK1048638A1 - Cyclopenteneone衍生物 - Google Patents
Cyclopenteneone衍生物Info
- Publication number
- HK1048638A1 HK1048638A1 HK02108074.0A HK02108074A HK1048638A1 HK 1048638 A1 HK1048638 A1 HK 1048638A1 HK 02108074 A HK02108074 A HK 02108074A HK 1048638 A1 HK1048638 A1 HK 1048638A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cyclopenteneone derivatives
- cyclopenteneone
- derivatives
- Prior art date
Links
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical class O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
- C07C69/40—Succinic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/75—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of acids with a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/80—Phthalic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- AIDS & HIV (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9929702.0A GB9929702D0 (en) | 1999-12-16 | 1999-12-16 | Chemical compounds and their uses |
PCT/GB2000/004868 WO2001044254A1 (en) | 1999-12-16 | 2000-12-18 | Cyclopenteneone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1048638A1 true HK1048638A1 (zh) | 2003-04-11 |
Family
ID=10866408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02108074.0A HK1048638A1 (zh) | 1999-12-16 | 2002-11-06 | Cyclopenteneone衍生物 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20030186941A1 (zh) |
EP (1) | EP1240171A1 (zh) |
JP (1) | JP2003516995A (zh) |
KR (1) | KR20020062349A (zh) |
CN (1) | CN1409715A (zh) |
AU (1) | AU2202401A (zh) |
CA (1) | CA2393972A1 (zh) |
GB (1) | GB9929702D0 (zh) |
HK (1) | HK1048638A1 (zh) |
IL (1) | IL150132A0 (zh) |
NO (1) | NO20022867L (zh) |
WO (1) | WO2001044254A1 (zh) |
ZA (1) | ZA200204458B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002352401A1 (en) * | 2001-12-14 | 2003-06-30 | Charterhouse Therapeutics Limited | Improvements in pharmaceutical compositions |
EP1456214A2 (en) * | 2001-12-14 | 2004-09-15 | Charterhouse Therapeutics Limited | Improvements in pharmaceutical compositions |
GB0218261D0 (en) * | 2002-08-06 | 2002-09-11 | Charterhouse Therapeutics Ltd | Improvements in pharmaceutically useful compounds |
GB0218260D0 (en) * | 2002-08-06 | 2002-09-11 | Charterhouse Therapeutics Ltd | Improvements in pharmaceutically useful compounds |
US9101601B2 (en) | 2012-01-09 | 2015-08-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating or preventing insulin resistance and associated diseases and conditions |
US9517224B2 (en) | 2012-11-15 | 2016-12-13 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Methods of treating patients infected with HIV and HTLV |
JP2016533329A (ja) * | 2013-09-25 | 2016-10-27 | ウィリアム マーシュ ライス ユニバーシティWilliam Marsh Rice University | Δ12−pgj3および関連化合物の合成 |
CN106518643B (zh) * | 2016-10-14 | 2019-02-15 | 宁波大学 | 一种环戊烯酮类化合物及其制备方法和用途 |
CN106966886B (zh) * | 2017-01-24 | 2020-06-16 | 宁波大学 | 一种环戊烯酮类化合物及其制备方法和应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954519A (en) * | 1987-04-28 | 1990-09-04 | Georgia Tech Research Corporation | Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents |
US4711895A (en) * | 1984-10-22 | 1987-12-08 | Teijin Limited | 4-hydroxy-2-cyclopentenone, process for production thereof, pharmaceutical composition comprising it |
JPS61205230A (ja) * | 1985-03-09 | 1986-09-11 | Nippon Iyakuhin Kogyo Kk | アルキリデンシクロペンテノン誘導体及びその製法 |
JPS6244A (ja) * | 1985-06-25 | 1987-01-06 | Nippon Iyakuhin Kogyo Kk | 2−ハロ−2−シクロペンテノン誘導体及びその製法 |
JPS62114933A (ja) * | 1985-11-13 | 1987-05-26 | Nippon Iyakuhin Kogyo Kk | 2−ハロ−2−シクロペンテノン誘導体及びその製法 |
JPS62129245A (ja) * | 1985-11-30 | 1987-06-11 | Nippon Iyakuhin Kogyo Kk | 2−ハロ−2−シクロペンテノン誘導体及びその製法 |
US6150090A (en) * | 1986-01-09 | 2000-11-21 | Massachusetts Institute Of Technology | Nuclear factors associated with transcriptional regulation |
AU615534B2 (en) * | 1988-04-19 | 1991-10-03 | Teijin Limited | 2-substituted-2-cyclopentenones |
US5216183A (en) * | 1988-04-19 | 1993-06-01 | Teijin Limited | Cyclopentanone/cyclopentenone derivative |
US5338844A (en) * | 1989-10-19 | 1994-08-16 | Teijin Limited | 2-substituted-2-cyclopentenone compound and anticancer agent and bone formation accelerator comprising same as active ingredient |
EP0659728A4 (en) * | 1992-09-10 | 1997-08-06 | Teijin Ltd | 4-HYDROXY-2-CYCLOPENTENONE DERIVATIVES AND CARCINOSTATICS AND OSTEOGENESIS PROMOTERS CONTAINING THEM. |
GB9418762D0 (en) * | 1994-09-16 | 1994-11-02 | Bayer Ag | Use of substituted cyclopentane-DI-and-triones |
IT1289250B1 (it) * | 1996-12-13 | 1998-09-29 | Consiglio Nazionale Ricerche | Impiego di 2 ciclopenten 1-one e suoi derivati come inibitori del fattore nf-kb |
IT1284853B1 (it) * | 1996-06-18 | 1998-05-22 | Consiglio Nazionale Ricerche | Impiego del 2-ciclopenten-1-one come induttore di hsp70. |
JP3790273B2 (ja) * | 1996-09-27 | 2006-06-28 | タカラバイオ株式会社 | シクロペンテノン類、その製造方法及び用途 |
ATE359999T1 (de) * | 1997-03-05 | 2007-05-15 | Takara Bio Inc | 4-organothio-2-cyclopentenonen und 3-organothio-2-cyclopentanonen, deren herstellungsverfahren und pharmazeutischen anwendungen |
AU730766B2 (en) * | 1997-03-11 | 2001-03-15 | Takara Bio Inc. | Cyclopentenone derivative |
EP0978278B1 (en) * | 1997-03-28 | 2004-09-01 | Takara Bio Inc. | 4,5-dihydroxy-2-cyclopenten-1-one for the treatment of diabetes mellitus |
US6284801B1 (en) * | 1997-04-01 | 2001-09-04 | Takara Shuzo Co., Ltd. | Antirheumatic agents |
EA002354B1 (ru) * | 1997-06-30 | 2002-04-25 | Такара Сузо Ко., Лтд. | Производные циклопентенона |
-
1999
- 1999-12-16 GB GBGB9929702.0A patent/GB9929702D0/en not_active Ceased
-
2000
- 2000-12-18 EP EP00985616A patent/EP1240171A1/en not_active Withdrawn
- 2000-12-18 AU AU22024/01A patent/AU2202401A/en not_active Abandoned
- 2000-12-18 US US10/168,036 patent/US20030186941A1/en not_active Abandoned
- 2000-12-18 KR KR1020027007791A patent/KR20020062349A/ko not_active Application Discontinuation
- 2000-12-18 WO PCT/GB2000/004868 patent/WO2001044254A1/en not_active Application Discontinuation
- 2000-12-18 JP JP2001544744A patent/JP2003516995A/ja not_active Withdrawn
- 2000-12-18 CN CN00817160A patent/CN1409715A/zh active Pending
- 2000-12-18 IL IL15013200A patent/IL150132A0/xx unknown
- 2000-12-18 CA CA002393972A patent/CA2393972A1/en not_active Abandoned
-
2002
- 2002-06-04 ZA ZA200204458A patent/ZA200204458B/en unknown
- 2002-06-14 NO NO20022867A patent/NO20022867L/no not_active Application Discontinuation
- 2002-11-06 HK HK02108074.0A patent/HK1048638A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN1409715A (zh) | 2003-04-09 |
JP2003516995A (ja) | 2003-05-20 |
US20030186941A1 (en) | 2003-10-02 |
NO20022867L (no) | 2002-08-12 |
EP1240171A1 (en) | 2002-09-18 |
IL150132A0 (en) | 2002-12-01 |
NO20022867D0 (no) | 2002-06-14 |
CA2393972A1 (en) | 2001-06-21 |
WO2001044254A1 (en) | 2001-06-21 |
KR20020062349A (ko) | 2002-07-25 |
GB9929702D0 (en) | 2000-02-09 |
ZA200204458B (en) | 2003-04-17 |
AU2202401A (en) | 2001-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23817A (en) | 4-Phenyl-pyridine derivatives | |
HUP0201535A2 (en) | 5-cyano-2-aminopyrimidine derivatives | |
IL148167A0 (en) | Amino-triazolopyridine derivatives | |
GC0000183A (en) | 3-Phenyl-pyridine derivatives | |
IL145739A0 (en) | 13-methyl-erythromycin derivatives | |
GC0000338A (en) | 5-Phenyl-pyrimidine derivatives | |
IL148837A0 (en) | Isoxazolecarboxamide derivatives | |
GC0000191A (en) | 4-Phenyl-pyrimidine derivatives | |
GB0026485D0 (en) | ›-Carboline derivatives | |
IL147636A0 (en) | 3-amino-2-benzyl-1-phenyl-propane derivatives | |
IL150132A0 (en) | Cyclopenteneone derivatives | |
GC0000256A (en) | Ethanesulfonyl-piperidine derivatives | |
AP2001002327A0 (en) | 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives | |
PL351407A1 (en) | Thio-oxindole derivatives | |
IL146282A0 (en) | Thio-oxindole derivatives | |
GB9907134D0 (en) | Antimor napthylcombretastatin derivatives | |
SI1178984T1 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives | |
HK1043987A1 (zh) | 硫-羥吲衍生物 | |
SI1200445T1 (en) | Thienopyranecarboxamide derivatives | |
SI1226131T1 (en) | Isoxazolecarboxamide derivatives |